Bausch + Lomb Balance Sheet
NYSE: BLCOHealth CareOphthalmic GoodsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb financial position
At the end of fiscal 2025, Bausch + Lomb reported total assets of $14.02 billion, up 4.1% from a year earlier against total liabilities of $7.50 billion. Shareholders' equity stood at $6.45 billion, or 46.0% of assets. The company held $383.0 million in cash and equivalents against $5.05 billion of debt, a net debt position of $4.67 billion.
The current ratio (current assets divided by current liabilities) was 1.55, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.78.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 383.00M | 305.00M | 331.00M | 354.00M | 174.00M | 238.00M |
| Receivables | 1.22B | 1.03B | 839.00M | 724.00M | 721.00M | — |
| Inventory | 976.00M | 1.04B | 1.03B | 628.00M | 572.00M | — |
| Total Current Assets | 2.98B | 2.79B | 2.74B | 2.14B | 1.64B | — |
| Property, Plant & Equipment | 1.76B | 1.49B | 1.39B | 1.30B | 1.23B | — |
| Goodwill | 4.76B | 4.52B | 4.58B | 4.51B | 4.59B | 4.68B |
| Intangible Assets | 3.28B | 3.49B | 3.59B | 2.06B | 2.26B | — |
| Total Assets | 14.02B | 13.47B | 13.44B | 11.14B | 10.82B | — |
| Accounts Payable | 388.00M | 389.00M | 522.00M | 370.00M | 239.00M | — |
| Short-Term Debt | 28.00M | 40.00M | 30.00M | 25.00M | 0 | — |
| Total Current Liabilities | 1.92B | 1.74B | 1.58B | 1.30B | 1.10B | — |
| Long-Term Debt | 5.02B | 4.74B | 4.53B | 2.41B | 0 | — |
| Total Liabilities | 7.50B | 6.92B | 6.52B | 4.04B | 1.42B | — |
| Shareholders' Equity | 6.45B | 6.47B | 6.85B | 7.03B | 9.33B | 9.99B |
| Retained Earnings | -931.00M | -571.00M | -254.00M | 6.00M | 0 | — |
| Total Debt | 5.05B | 4.78B | 4.56B | 2.44B | 0 | — |
| Net Cash (Debt) | -4.67B | -4.48B | -4.23B | -2.08B | 174.00M | 238.00M |
| Shares Outstanding | 354.21M | 352.40M | 350.91M | 350.00M | 350.00M | — |
This table shows 6 annual periods of Bausch + Lomb's balance sheet, from FY 2025 back to FY 2020, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow BLCO's reporting calendar. What is a balance sheet?